Profile
AARD VRTX REGN SGEN ALNY ARGX
Company Name Aardvark Therapeutics, Inc. Common Stock Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $333.68M $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.02K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Dr. Tien-Li Lee M.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
AARD VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 1
Quant Rating Sell Sell Buy Neutral Strong Sell Strong Sell
Trading
AARD VRTX REGN SGEN ALNY ARGX
Last Close $15.38 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $17.11 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 - $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -10.11 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 0 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
AARD VRTX REGN SGEN ALNY ARGX
1 Month Return 46.48 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return 65.2 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return 0 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return 0 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return 0 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return 0 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AARD VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2202.36 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
AARD VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -15.48 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -1285.33 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -18.04 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 89.24 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -3336.91 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.84 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.84 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 1146.37 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.05 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -3336.91 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -13.77 -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM -8.38 -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM -8.38 -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
AARD VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.02B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.02B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -1.59 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
AARD VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.13B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $-0.05B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0.01B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.08B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
AARD VRTX REGN SGEN ALNY ARGX
Net Income $-0.02B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.67
ABCL AbCellera Biologics Inc. 3.7376
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.91
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0292
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.195
ABVC ABVC BioPharma, Inc. 2.175
ABVX Abivax SA American Depositary Shares 7.15
ACAD ACADIA Pharmaceuticals Inc. 22.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6714
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.49
ACIU AC Immune SA 2.095
ACLX Arcellx, Inc. 64.835
ETFs With Exposure to AARD
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 302.04
VXF Vanguard Extended Market Index Fund 0 191.48
VTHR Vanguard Russell 3000 Index Fund 0 270.2
VTWV Vanguard Russell 2000 Value Index Fund 0 138.785
VTWG Vanguard Russell 2000 Growth Index Fund 0 208.045
VTWO Vanguard Russell 2000 Index Fund 0 87.09
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 101.78
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.45
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.44
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.65
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.66
VEMPX Vanguard Extended Market Index InstlPlus 0 354.51
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 273.35
Unlock